Leading generics pharmaceutical company
More drugs are in short supply for longer periods of time due to a fundamentally flawed pharmaceutical supply chain, according to a new report. The number of ongoing drug shortages has increased from 2017 to 2018 after declining from a peak in 2011. Shortages have also been lasting longer, in some cases more than eight […]
Consumer Reports examines why prescription drug prices are rising so sharply—and how to lower your drug costs As consumers, we know the difference between products we want and products we need. For luxury or convenience items, it’s easy enough to hold off on a purchase if our budget demands it—but for the things we can’t […]
Medicare could have saved nearly 90% of spending on angiotensin converting enzyme inhibitors and angiotensin-II-receptor blockers in 2016 and 2017 through generic substitute or therapeutic interchange, according to study results published in JAMA Internal Medicine. “Prescription drug spending accounts for an increasing share of U.S. health care costs.” Mathew E. Growdon, MD, MPH, of the […]
As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines. With the escalating cost of healthcare facilities, many people in India […]
BARCELONA — In 2014, ViiV Healthcare, a pharmaceutical company dedicated to ending the HIV epidemic, and the Medicines Patent Pool, an organization funded primarily by Unitaid to increase access to medicines in lower-income countries, signed two voluntary licensing agreements. The agreements allowed generic manufacturers to produce and sell low-cost versions of the ViiV-developed HIV drug dolutegravir in all low- […]
It’s pretty much just two women who name the 200-plus drugs that come out every year Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be nearly identical to their name-brand […]
Here’s what to look out for — other than the packaging Prescription drug costs are an issue for millions of Americans, many of whom use prescription medicine on a daily basis. And since Medicare doesn’t always cover brand-name drugs, it’s worth giving some thought to what exactly, if any, are the differences between brand name and […]
Latest Mediscor review says generic utilisation rate more than doubled from 27.7% in 2002 to 62.4% in 2018 The use of cheaper generic alternatives that are no longer patent-protected rose to an all-time high in the private sector in 2018, according to the latest Mediscor review. The trend highlights the continued impact of the […]
This morning, Health Canada announced the final amendments to the Patented Medicines Regulations (see news release here and RIAS here). These amendments represent the first substantive revision to the Regulations since their introduction in 1987, and a significant departure from the existing framework. The amended Regulations will come into force on July 1, 2020 […]
There is a question about what role race and wealth play in how much attention and funding the disease receives. Sickle cell disease affects about 100,000 Americans, most of them African-Americans. There are few treatments for it, and experts say not enough is being done to prevent complications. Just recently, the Centers for Medicare […]
